Document is current
Any future updates will be listed below
-
Authors
Nurm, Miriam https://orcid.org/0000-0001-7156-8216
Reigo, Anu https://orcid.org/0009-0008-0226-3396
Annilo, Tarmo
Toomsoo, Toomas https://orcid.org/0009-0007-9561-5786
Nõukas, Margit
Nikopensius, Tiit
Pankratov, Vasili https://orcid.org/0000-0001-7928-4402
Reisberg, Tuuli https://orcid.org/0000-0002-1193-5616
Hudjashov, Georgi
,
Metspalu, Andres
Milani, Lili
Esko, Tõnu
Mägi, Reedik
Nelis, Mari
Haller, Toomas
Tõnisson, Neeme https://orcid.org/0000-0002-1715-3164
-
Funding
Funding for this research was provided by:
Eesti Teadusagentuur (PRG555)
Eesti Teadusagentuur (PRG555)
Eesti Teadusagentuur (PRG555)
Eesti Teadusagentuur (PRG555)
Eesti Teadusagentuur (PRG555)
Eesti Teadusagentuur (PRG555)
Estonian Biobank's Personalized Medicine Centre of Excellence
EC | Horizon 2020 Framework Programme (810645)
EC | European Regional Development Fund (MOBEC008)
- License Information
-
More Information
Article History
Received: 20 March 2024
Revised: 5 November 2024
Accepted: 3 December 2024
First Online: 14 December 2024
Competing interests
: The authors have no competing interests to declare.
: The authors have no competing interests to declare.The activities of the Estonian Biobank are regulated by the Human Genes Research Act, which was adopted in 2000 specifically for the operations of the Estonian Biobank. Individual-level data analysis at the Estonian Biobank for the purpose of this study was carried out under ethical approval nos. 1.1-12/2356 and 1.1-12/624 (and all further amendments) from the Estonian Committee on Bioethics and Human Research (Estonian Ministry of Social Affairs), using data according to release application nos. J11 3-10/GV-8368 and S38 6-7/GI/ 27773 from the Estonian Biobank.
